Information:
Fel:
ID
32693
Beskrivning
Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis
Nyckelord
Versioner (1)
- 2018-11-12 2018-11-12 -
Rättsinnehavare
GSK group of companies
Uppladdad den
12 november 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Estimation of Dose Proportionality of Darapladib - 107038
Pharmacodynamics Post Dose Data - [Analyte and PD sample type]
- StudyEvent: ODM
Similar models
Pharmacodynamics Post Dose Data - [Analyte and PD sample type]
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Dosing date
Item
Dosing date
date
Dosing time
Item
Dosing time
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Date of sample
Item
Date of sample
date
Time of sample
Item
Time of sample
time
Inga kommentarer